Press Releases :: Nighthawk Biosciences, Inc. (HTBX)

Apr 14, 2022 12:35pm EDT

Heat Biologics’ Announces Planned Investor and Media Livestream Event to Discuss Latest Developments

Mar 25, 2022 8:00am EDT

Heat Biologics Unveils Enhanced Allogeneic Cell Manufacturing Process

Mar 23, 2022 8:30am EDT

Heat Biologics Announces Appointment of Greg Burel, Former Director of the Strategic National Stockpile, to its Biothreat Advisory Board and as Senior Advisor to the Company

Mar 14, 2022 8:00am EDT

Heat Biologics Provides Year-End 2021 Business Update

Feb 02, 2022 4:05pm EST

Heat Biologics Announces Planned Transfer to the NYSE American

Jan 31, 2022 7:30am EST

Elusys Therapeutics Finalizes HHS Contract to Deliver ANTHIM®, Its Treatment for Inhalation Anthrax, to the U.S. Department of Health and Human Services

Jan 12, 2022 8:00am EST

Heat Biologics Announces New PTX-35 Preclinical Data in Organ Transplantation and Provides Update on HS-110

Dec 21, 2021 7:30am EST

Heat Biologics Announces Planned Acquisition of Elusys Therapeutics

Nov 30, 2021 7:30am EST

Heat Biologics Unveils RapidVax®, A Novel Cellular Vaccine Platform Targeting Known and Unknown Emerging Biological Threats

Nov 10, 2021 4:05pm EST

Heat Biologics Provides Third Quarter 2021 Business Update

rss_feed News RSS

OUR ECOSYSTEM